Ulf Hannelius

No open positions remaining

Net worth: 48 898 $ as of 2026-06-29

51 year

5 connections

Consumer Services

Health Technology

Technology Services

Profile

Ulf Hannelius is currently Chairman at Diamyd Biomanufacturing AB and Director at Mainly AB since 2021.
Formerly, Dr. Hannelius was President & Chief Executive Officer at Diamyd Medical AB from 2016 to 2026.
Education includes a doctorate from Karolinska Institutet and an MBA from Stockholm School of Economics.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DIAMYD MEDICAL AB CLASS B 0.35%	2025-08-30	463,973 ( 0.35% )	48 898 $	2026-06-29

Ulf Hannelius active positions

Companies	Position	Start
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Director/Board Member	2021-02-21

All active positions of Ulf Hannelius

Former positions of Ulf Hannelius

Companies	Position	End
DIAMYD MEDICAL AB	Chief Executive Officer	2026-04-21

See the detail of Ulf Hannelius's experience

Training of Ulf Hannelius

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ulf Hannelius's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Diamyd Medical AB Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes	Health Technology
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Technology Services